Medicine Matters rheumatology  Por  arte de portada

Medicine Matters rheumatology

De: Springer Healthcare
  • Resumen

  • Interviews with clinical experts, discussing key issues in rheumatology.
    Springer Healthcare, part of the Springer Nature group
    Más Menos
activate_primeday_promo_in_buybox_DT
Episodios
  • Repurposing rheumatology drugs for COVID-19: TNF inhibitors (with Philip Robinson)
    Mar 9 2021

    Philip Robinson discusses why TNF inhibitors may be a favorable treatment option for COVID-19 and outlines the trials that are currently underway.

    Más Menos
    17 m
  • Repurposing rheumatology drugs for COVID-19: Interleukin inhibitors
    Feb 11 2021

    Cristina Mussini discusses the current data on interleukin inhibitors for the treatment of COVID-19 and explores why tocilizumab has been associated with beneficial outcomes in some studies but not others.

    Más Menos
    19 m
  • Repurposing rheumatology drugs for COVID-19: JAK inhibitors
    Jan 25 2021

    Marwan Bukhari talks about the rationale behind investigating baricitinib and other JAK inhibitors for the treatment of COVID-19 and outlines the current efficacy data.

    Más Menos
    11 m

Lo que los oyentes dicen sobre Medicine Matters rheumatology

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.